Lusek Medicare Private Limited

Lusek Medicare Private Limited - pharma in Bhandup, Maharashtra, India. FY 2026 financials and compliance.
CIN U62013MH2019PTC334561 Incorporated 17 December 2019 ROC Mumbai HQ Bhandup, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹8.21 Lakh
▲ 932.00% YoY
EBITDA · FY 2025
*****
▲ 14.00% YoY
Net profit · FY 2025
*****
▲ 12.00% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
7 yrs
Est. 2019
Last financials
Mar 2025
Balance sheet date

About Lusek Medicare Private Limited

Data last updated: 21 February 2026

Lusek Medicare Private Limited is a private limited company based in Bhandup, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 December 2019, the company has been in operation for over 7 years.

Registered with ROC Mumbai under CIN U62013MH2019PTC334561.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Archana Gupta and Narender Kumar.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Maharashtra, India – 400078.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.21 Lakh, reflecting significant growth compared to the previous year.

Company Details of Lusek Medicare Private Limited
CIN U62013MH2019PTC334561
Registration Number 334561
Incorporation Date 17 December 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Key People
Archana Gupta Director Narender Kumar Director Ajai Kumar Srivastava Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Sarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Maharashtra, India – 400078
  • Industry
    Pharma, Drug Formulation & Development
Company report
Lusek Medicare Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Lusek Medicare Private Limited report

Financials, compliance, directors, charges, ownership and filings for Lusek Medicare Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Lusek Medicare Private Limited

Lusek Medicare Private Limited has one previous CIN (Corporate Identification Number): U24290MH2019PTC334561. The current CIN is U62013MH2019PTC334561, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U62013MH2019PTC334561 Current
U24290MH2019PTC334561 Previous

Business Activity of Lusek Medicare Private Limited

Lusek Medicare Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including manufacture of chemicals and chemical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing 20 Manufacture of chemicals and chemical products *********

Board of Directors of Lusek Medicare Private Limited

Lusek Medicare Private Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Archana Gupta
Also directs: Lusek Medicare Private Limited
Director 17 Dec 2019 6 Years 6 Months Current
Narender Kumar
Also directs: Lusek Medicare Private Limited
Director 17 Dec 2019 6 Years 6 Months Current
Ajai Kumar Srivastava
Also directs: Lusek Medicare Private Limited, Ewaps Technologies Private Limited, C-Pearl It Solutions Private Limited
Director 02 Aug 2025 0 Years 11 Months Current
View all directors

Financials of Lusek Medicare Private Limited FY 2025 filings available

Lusek Medicare Private Limited reported revenue of ₹8.21 Lakh (up 932% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹8.21 Lakh ▲ 932%
Profit
***** ▲ 12%
EBITDA
***** ▲ 14%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Lusek Medicare Private Limited

Lusek Medicare Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Lusek Medicare Private Limited

View historical data on people associated with Lusek Medicare Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Lusek Medicare Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Lusek Medicare Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Lusek Medicare Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Lusek Medicare Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Lusek Medicare Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Lusek Medicare Private Limited

MSME Payment Delays by Lusek Medicare Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Lusek Medicare Private Limited

Subsidiaries & Group Companies of Lusek Medicare Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Lusek Medicare Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Lusek Medicare Private Limited

MCA Filings & Documents of Lusek Medicare Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Lusek Medicare Private Limited

Activity
30 Sep 2025
Lusek Medicare Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Directors
02 Aug 2025
Ajai Kumar Srivastava was appointed as a Director on 02 Aug 2025 & has been associated with this company since 11 months 11 days.
Activity
31 Mar 2025
Lusek Medicare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
17 Dec 2019
Archana Gupta was appointed as a Director on 17 Dec 2019 & has been associated with this company since 6 years 6 months.
Directors
17 Dec 2019
Narender Kumar was appointed as a Director on 17 Dec 2019 & has been associated with this company since 6 years 6 months.
Activity
17 Dec 2019
Lusek Medicare Private Limited was registered on 17 Dec 2019 with Roc Mumbai I & aged 6 years 6 months as per MCA records.

Frequently Asked Questions about Lusek Medicare Private Limited

Lusek Medicare Private Limited is an active private limited company in the pharma sector based in Bhandup, Maharashtra, India. It was incorporated on 17 December 2019 (7+ years old) and is registered under CIN U62013MH2019PTC334561.

Lusek Medicare Private Limited reported revenue of ₹8.21 Lakh for FY 2025 (up 932.00% YoY).

The current directors of Lusek Medicare Private Limited are:

The primary industry of Lusek Medicare Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Lusek Medicare Private Limited can be reached at the registered office: Sarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Maharashtra, India – 400078.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available